IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Oxidative Stress Biomarkers in Hypertension
- Fountoulakis P. , et al.
2. A Systematic Review on Advances in Management of Oxidative Stress-Associated Cardiovascular Diseases
- Jin S. , et al.
3. Clinical Properties and Non-Clinical Testing of Mineralocorticoid Receptor Antagonists in In Vitro Cell Models
- Varda L. , et al.
4. Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors
- Badran M. , et al.
5. In Silico Analysis of Antioxidant Phytochemicals with Potential NADPH Oxidase Inhibitory Effect
- Mhya D.H. , et al.
6. Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease
- Nakamura T. , et al.
7. The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
- Hollenberg M.D. , et al.
8. Therapeutic potential of spironolactone in ankylosing spondylitis patients: Relation to disease activity and functional status
- Verma I. , et al.
9. Parenteral Nutrition and Cardiotoxicity
- van Nispen J. , et al.
10. Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
- Lin X. , et al.
11. COVID-19—the potential beneficial therapeutic effects of spironolactone during SARS-CoV-2 infection
- Kotfis K. , et al.
12. SRC-3 Knockout Attenuates Myocardial Injury Induced by Chronic Intermittent Hypoxia in Mice
- Wang W. , et al.
13. Research progress of the effect of cell-specific mineralocorticoid receptor on blood pressure regulation
- Qian-Yu M. , et al.
14. Impact of mineralocorticoid receptor antagonist in renal transplant patients: a systematic review and meta-analysis of randomized controlled trials
- Abdelhakim A.M. , et al.
15. Vascular and inflammatory mineralocorticoid receptors in kidney disease
- Barrera-Chimal J. , et al.
16. Vascular mineralocorticoid receptor activation and disease
- Barrera-Chimal J. , et al.
17. Spironolactone ameliorates endothelial dysfunction through inhibition of the AGE/RAGE axis in a chronic renal failure rat model
- Wang C.C. , et al.
18. Spironolactone reduces oxidative stress in living donor kidney transplantation: A randomized controlled trial
- Morales-Buenrostro L.E. , et al.
19. Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
- Barrera-Chimal J. , et al.
20. Cellular death, reactive oxygen species (ROS) and diabetic complications review-Article
- Volpe C.M.O. , et al.
21. Spironolactone protects against diabetic cardiomyopathy in streptozotocin-induced diabetic rats
- Liu W. , et al.
22. Therapeutic effects of spironolactone on a collagen-induced arthritis model of rheumatoid arthritis
- Verma I. , et al.
23. Roles of aldosterone in vascular calcification: An update
- Gao J. , et al.